- Trials with a EudraCT protocol (10,988)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (18,700)
10,988 result(s) found.
Displaying page 53 of 550.
EudraCT Number: 2004-004620-12 | Sponsor Protocol Number: dyspnoea1 | Start Date*: 2005-01-14 |
Sponsor Name:Royal Marsden Hospital | ||
Full Title: Assessment of normal release morphine in the management of dyspnoea | ||
Medical condition: Breathlessness of any cause in cancer patients are identified and treated with normal release morphine which has been shown to be both effective and safe.The idea of the trial is to see if there wi... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2006-007019-25 | Sponsor Protocol Number: Delusional Parasitosis 1/Dec 2006 | Start Date*: 2008-01-21 | |||||||||||
Sponsor Name:Barts and the London NHS Trust | |||||||||||||
Full Title: Pilot open trial of efficacy of Risperidone in Delusional Parasitosis | |||||||||||||
Medical condition: Delusional Parasitosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-001889-33 | Sponsor Protocol Number: 1790 | Start Date*: 2007-08-24 | ||||||||||||||||
Sponsor Name:North Bristol NHS Trust | ||||||||||||||||||
Full Title: Does an 8 week course of Ambulatory Oxygen Increase Diffuse Parenchymal Lung Diseases Patients Ability to Perform a 6 Minute Walk Test and/or Improve Patients Perception of Quality of Life as measu... | ||||||||||||||||||
Medical condition: Patients enrolled will have a diagnosis of restrictive lung disease diagnosed by a High Resolution CT scan, reduced gas transfer result (obtained from pulmonary function tests) and low lung volumes... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2006-004136-73 | Sponsor Protocol Number: CTMK05 | Start Date*: 2006-09-14 | |||||||||||
Sponsor Name:Thornton & Ross Limited | |||||||||||||
Full Title: A randomised, controlled, assessor-blind, clinical trial to demonstrate superiority of Hedrin 4% dimeticone lotion compared with Derbac-M 0.5% malathion aqueous liquid in the treatment of head lice | |||||||||||||
Medical condition: Head louse infestation | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-000262-20 | Sponsor Protocol Number: DPOD III | Start Date*: 2007-07-25 | |||||||||||
Sponsor Name:Stanmore Clinical Research Facility Ltd | |||||||||||||
Full Title: A phase III, 7 days randomised, double-blind, placebo-controlled, parallel group study to assess efficacy of DPZ for reducing the symptoms of post-operative delirium after an elective hip or knee r... | |||||||||||||
Medical condition: Post-operative delirium. | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-002202-30 | Sponsor Protocol Number: R207910BAC2001 | Start Date*: 2004-10-18 |
Sponsor Name:Tibotec Pharmaceuticals Ltd. | ||
Full Title: An open label study to evaluate the effects on Mycobacterium tuberculosis, safety, tolerability and pharmacokinetics of single doses of R207910, in treatment naive patients with mycobacterium tuber... | ||
Medical condition: Tuberculosis | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-004541-34 | Sponsor Protocol Number: 21092005 | Start Date*: 2006-02-14 |
Sponsor Name:South Manchester University Healthcare Trust | ||
Full Title: The Effect of Enteral Administration of Synbiotics Upon Infection Rates in Major Burns | ||
Medical condition: Major burn injuries: Thermal related trauma with burn injury involving significant proportions of the total body surface area, as defined by age: Adults (>=17 years old): >= 15% body surface area ... | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2007-003418-32 | Sponsor Protocol Number: GS-US-104-0352 | Start Date*: 2007-12-18 | |||||||||||
Sponsor Name:Gilead Sciences Incorporated | |||||||||||||
Full Title: A Phase III, Randomised, Open- Label Study Comparing the Safety and Efficacy of Switching Stavudine or Zidovudine to Tenofovir Disoproxil Fumarate versus Continuing Stavudine or Zidovudine in Virol... | |||||||||||||
Medical condition: HIV-1 infected children (2 years to less than 12 years), who are virologically suppressed with HIV-1 RNA less than 400 copies/mL on their current antiretroviral regimen. | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-004231-53 | Sponsor Protocol Number: 506067 | Start Date*: 2004-12-22 |
Sponsor Name:Royal Devon and Exeter NHS Foundation Trust | ||
Full Title: The Effect Of Antihypertensive Treatment With Lisinopril and Labetalol on Baroreflex Sensitivity in Stroke | ||
Medical condition: Stroke | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2004-004243-21 | Sponsor Protocol Number: M200-1205 | Start Date*: 2005-03-15 |
Sponsor Name:PDL BioPharma, Inc. | ||
Full Title: Phase 2 Open-Label Study of Volociximab (M200) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Cancer Not Previously Treated with Chemotherapy | ||
Medical condition: metastatic pancreatic cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2004-004247-22 | Sponsor Protocol Number: RES104033 | Start Date*: 2005-06-07 |
Sponsor Name:GlaxoSmithKline Research & Development Limited | ||
Full Title: A 28-day, Randomised, Double-Blind, Active Comparator, Controlled Study to Assess the Effects of Rosiglitazone, Inhaled Corticosteroid, Theophylline and Theophylline Plus Inhaled Corticosteroid on ... | ||
Medical condition: Smokers that are asthmatic | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-004652-13 | Sponsor Protocol Number: PSD502-PM-001 | Start Date*: 2006-02-01 |
Sponsor Name:PLETHORA SOLUTIONS LIMITED | ||
Full Title: Phase II, multi centre, randomised, double blind, placebo controlled, pilot study to determine efficacy, safety, tolerability and preliminary pharmacokinetics of PSD502 in the management of pain fr... | ||
Medical condition: management of pain from donor sites in burns subjects undergoing skin grafts | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2006-001386-42 | Sponsor Protocol Number: REC no:06/Q0403/25 | Start Date*: 2006-07-06 |
Sponsor Name:Imperial College | ||
Full Title: The timing of intra-vitreal (4mg) triamcinolone acetonide, in addition to verteporfin photodynamic therapy for choroidal neovascularisation, in age-related macular degeneration: a prospective rando... | ||
Medical condition: Submacular choroidal neovascularisation in Age-related Macular Degeneration | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-000053-62 | Sponsor Protocol Number: sph/itu/0001 | Start Date*: 2007-06-18 | |||||||||||
Sponsor Name:Ashford & St. Peter's Hospitals NHS Trust | |||||||||||||
Full Title: The effects of helium-oxygen gas mixture (Heliox) on airway pressures in mechanically ventilated adult patients with acute lung injury | |||||||||||||
Medical condition: Acute lung injury | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-000497-23 | Sponsor Protocol Number: 07/Q0703/18 | Start Date*: 2007-05-02 | ||||||||||||||||
Sponsor Name:King's College Hospital NHS Foundation Trust [...] | ||||||||||||||||||
Full Title: Do sulphponylureas preserve cortical function during hypoglycaemia in patients with type 1 diabetes and hypoglycaemia unawareness? | ||||||||||||||||||
Medical condition: We are testing the hypothesis that closing the K ATP channels using sulphonylureas (glibenclamide) during experimental insulin induced hypoglycaemia can help retain cerebral function and help enhan... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2006-001982-41 | Sponsor Protocol Number: RAE04 | Start Date*: 2006-10-03 | |||||||||||
Sponsor Name:Bradford Teaching Hospitals NHS Foundation Trust | |||||||||||||
Full Title: An evaluation of the safety and effectiveness of combination therapy using the thiazolidinedione pioglitazone alongside insulin in type 2 diabetes mellitus. | |||||||||||||
Medical condition: Type 2 Diabetes Mellitus | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-002208-32 | Sponsor Protocol Number: PAR06 | Start Date*: 2006-08-14 |
Sponsor Name:York Hospital NHS Trust | ||
Full Title: A comparison of the analgesic efficacy of oral and intravenous paracetamol (perfalgan) in a day case setting | ||
Medical condition: We will perform a double blind randomised comparison of oral paracetamol versus intravenous paracetamol (Perfalgan) in patients undergoing knee arthroscopy in a day surgery setting. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2007-006761-32 | Sponsor Protocol Number: A 091152 | Start Date*: 2008-04-15 | |||||||||||
Sponsor Name:Cambridge University Hospitals NHS Foundation Trust and the University of Cambridge | |||||||||||||
Full Title: Vulval intraepithelial neoplasia: immune responses to human papillpmavirus. | |||||||||||||
Medical condition: Vulval intraepithelial neoplasia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-001571-37 | Sponsor Protocol Number: AAV2/2-hRPE65p-hRPE65 | Start Date*: 2006-12-14 | |||||||||||
Sponsor Name:University College London | |||||||||||||
Full Title: AN OPEN-LABEL DOSE ESCALATION STUDY OF AN ADENO-ASSOCIATED VIRUS VECTOR (AAV2/2-hRPE65p-hRPE65) FOR GENE THERAPY OF SEVERE EARLY-ONSET RETINAL DEGENERATION | |||||||||||||
Medical condition: The condition to be investigated is severe early-onset inherited retinal degeneration due to defects in the gene encoding RPE65 | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-010956-93 | Sponsor Protocol Number: HM09/8885 | Start Date*: 2009-09-17 | |||||||||||
Sponsor Name:University of Leeds [...] | |||||||||||||
Full Title: Randomised comparisons, in myeloma patients of all ages, of thalidomide, lenalidomide, carfilzomib and bortezomib induction combinations, and of lenalidomide and combination lenalidomide vorinostat... | |||||||||||||
Medical condition: Newly diagnosed patients with symptomatic myeloma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
